Abstract
Serum fluorescent antibody levels against Entamoeba histolytica were determined in patients with amoebic infection and in control cases. Titres of 1: 64 or above were obtained only in cases of active or recent amoebic infection, and were recorded in 75·0% of intestinal cases and in 95·2% of extraintestinal cases. Titres given by symptomless carriers of Entamoeba histolytica, though not exceeding 1: 32, were proportionately higher than those obtained in normal subjects or in patients with non-amoebic disorders.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Boonpucknavig S., Nairn R. C. Serological diagnosis of amoebiasis by immunofluorescence. J Clin Pathol. 1967 Nov;20(6):875–878. doi: 10.1136/jcp.20.6.875. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Goldman M. Evaluation of a fluorescent antibody test for amebiasis using two widely differing ameba strains as antigen. Am J Trop Med Hyg. 1966 Sep;15(5):694–700. doi: 10.4269/ajtmh.1966.15.694. [DOI] [PubMed] [Google Scholar]
- Jeanes A. L. Indirect fluorescent antibody test in diagnosis of hepatic amoebiasis. Br Med J. 1966 Jun 11;1(5501):1464–1464. doi: 10.1136/bmj.1.5501.1464. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mullan D. P., Ward A. M., Shah S., Jeanes A. L. Diagnostic value of liver function tests and Entamoeba histolytica antibody studies in East Africans. J Clin Pathol. 1967 Mar;20(2):180–184. doi: 10.1136/jcp.20.2.180. [DOI] [PMC free article] [PubMed] [Google Scholar]